
Science Meeting Calendar
January 12
NO MEETING
​​
January 26
Neal Fedarko, PhD. -- Special Meeting
Johns Hopkins University
​
February 9
TBD
TBD
​​​
February 23
TBD
TBD
​
March 9
TBD
TBD
​​
March 23
Carlos Giovanni Silva García, Ph.D.
Assistant Professor of Molecular Biology, Cell Biology, & Biochemistry
Brown University
​
April 6
Gene Ables, Ph.D.
​​
April 20
TBD
TBD
​
May 4
Shyni Leela, Ph.D.
​​
May 18
Jay Johnson, Ph.D.
​
June 8
Dwight Mattocks
​​
June 22
Diana Cooke
​​
July 13
Sailendra Nichenametla, Ph.D.
​​
July 27
Brad Johnson, MD, Ph.D.
​​
August - NO MEETINGS
​
September 14
Shyni Leela, Ph.D.
​​​
September 28
TBD
TBD
​​
October 19
Jason Plummer
​
November 2
TBD
TBD
​
November 16
​​TBD
TBD
​
December 7
Gene Ables, Ph.D.
Jay Johnson, Ph.D.
Sailendra Nichenametla, Ph.D.
Year-end Reports
​
​
​

Our Founder
Dr. Norman Orentreich
1922 -2019
Norman Orentreich received his MD degree from New York University College of Medicine in 1948. He became a diplomate of the National Board of Medical Examiners in 1949 and American Board of Dermatology in 1953. During his post-graduate training at New York University’s Skin and Cancer hospital, Dr. Orentreich pioneered the research, creation, and performance of the very first hair transplant to treat male pattern baldness.
​
After having established his dermatology practice (OMG, LLP), he went on to found the biomedical research organization known as the Orentreich Foundation for the Advancement of Science, Inc. (OFAS). In 1968, Dr. Orentreich collaborated with Carol Phillips and the Lauder family to develop the internationally renowned skincare product line, Clinique. In 1970, he became the first President of the American Society for Dermatologic Surgery. Dr. Orentreich created and developed multiple procedures and treatments for skin, hair, and nail maintenance. He invented and patented medicines and medical devices for rejuvenating scarred and aging skin. He also wrote hundreds of articles and book chapters for medical textbooks and journals.
​
Under Dr. Orentreich’s guidance, research at OFAS expanded to encompass aging, cancer, dermatology, and serum biomarkers, resulting in numerous peer-reviewed publications.
Dr. Orentreich passed away on January 23, 2019; however, his legacy prevails as OFAS continues its dedication to the prevention, suspension, or reversal of those disorders that decrease the quality or length of life.
